Yi Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yi Zhou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Hailiang Hu
Department of Biochemistry, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Technology, Shenzhen, China
1 shared publication - Haozhe Zhang
Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China
1 shared publication - Junqi Hu
Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China
1 shared publication - Rajiv Kumar Sah
Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China
1 shared publication - Zengzhen Xing
Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China
1 shared publication
Latest Publications
- Open Access
- 4 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13521
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.
- 4 November 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13521
Open AccessAndrogen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.